Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bruker (BRKRP) Operating Expenses (2016 - 2025)

Bruker's Operating Expenses history spans 16 years, with the latest figure at $372.9 million for Q4 2025.

  • For Q4 2025, Operating Expenses fell 11.47% year-over-year to $372.9 million; the TTM value through Dec 2025 reached $1.5 billion, up 8.1%, while the annual FY2025 figure was $1.5 billion, 8.1% up from the prior year.
  • Operating Expenses reached $372.9 million in Q4 2025 per BRKRP's latest filing, down from $431.2 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $431.2 million in Q3 2025 to a low of $189.6 million in Q1 2021.
  • Average Operating Expenses over 5 years is $282.6 million, with a median of $256.3 million recorded in 2023.
  • Peak YoY movement for Operating Expenses: skyrocketed 39.12% in 2023, then fell 11.47% in 2025.
  • A 5-year view of Operating Expenses shows it stood at $216.2 million in 2021, then grew by 8.65% to $234.9 million in 2022, then soared by 39.12% to $326.8 million in 2023, then grew by 28.89% to $421.2 million in 2024, then fell by 11.47% to $372.9 million in 2025.
  • Per Business Quant, the three most recent readings for BRKRP's Operating Expenses are $372.9 million (Q4 2025), $431.2 million (Q3 2025), and $346.0 million (Q2 2025).